Products
| Product | Indication | Corporate Partner |
Market Territory |
Explanatory Notes |
|---|---|---|---|---|
| Sensipar® (cinacalcet HCI) |
Secondary HPT | Amgen | U.S. | Market Launch April 2004 discovered by NPS; developed/marketed by Amgen |
| Mimpara® (cinacalcet) |
Secondary HPT | Amgen | U.S. | Market Launch April 2004 discovered by NPS; developed/marketed by Amgen |
| Preotact® (parathyroid hormone) |
Osteoporosis | Nycomed | E.U. | Market Launch June 2006 discovered and developed by NPS |
Sensipar®, Mimpara® are registered trademarks owned by Amgen Inc.
Preotact™ is a trademark owned by NPS Pharmaceuticals, Inc. Full generic name for Preotact™ is "parathyroid hormone (rDNA origin) for injection"